New Radiation Protection Material

Radiation Shield Technologies announced today the acquisition of two additional United States Patents, #6,841,791 and #6,828,578.

In September 2002, RST introduced Demron. Since that time, Demron has been incorporated into a number of garments such as full-body nuclear, biological, and chemical (NBC) suits, tactical anti-nuclear vests, high-energy nuclear suppression blankets, and most recently, medical x-ray vests and aprons.

Demron is revolutionary material because it is lead-free, toxin-free, and PVC-free nuclear blocking material. It also has the unique ability to allow for heat dissipation and resist chemical permeation. Additionally, Demron is crack resistant. Its ability to block radiation has been confirmed by a number of prominent universities and government labs. Demron is an advanced radiopaque nano-polymeric compound that is fused between layers of fabric and manufactured into a number of lightweight nuclear blocking garments. RST's ISO 9000 partners, Kappler and Point Blank, manufacture these garments.

Demron was originally developed over 10 years ago, by surgeon Ronald F. DeMeo, M.D., M.B.A. Demron received its first patent (#6,281,515) in 2001 and its second (#6,459,091) in 2002.

According to Dr. DeMeo, "These two additional patents are significant because the additional 193 patent claims allow RST to fully capture all of Demron's market potential."

http://www.radshield.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.